Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Ludmila Ferreira de Almeida Fiuza"'
Autor:
Marianne Rocha-Hasler, Gabriel Melo de Oliveira, Aline Nefertiti da Gama, Ludmila Ferreira de Almeida Fiuza, Anna Frieda Fesser, Monica Cal, Romina Rocchetti, Raiza Brandão Peres, Xue Li Guan, Marcel Kaiser, Maria de Nazaré Correia Soeiro, Pascal Mäser
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 11 (2021)
Azoles such as posaconazole (Posa) are highly potent against Trypanosoma cruzi. However, when tested in chronic Chagas disease patients, a high rate of relapse after Posa treatment was observed. It appears that inhibition of T. cruzi cytochrome CYP51
Externí odkaz:
https://doaj.org/article/ee5ab12cf3d84660be77eec921094bc6
Autor:
Carlos Fernando Araujo-Lima, Rita de Cássia Castro Carvalho, Raiza Brandão Peres, Ludmila Ferreira de Almeida Fiuza, Bárbara Verena Dias Galvão, Frederico S. Castelo-Branco, Mônica Macedo Bastos, Nubia Boechat, Israel Felzenszwalb, Maria de Nazaré Correia Soeiro
Publikováno v:
Acta Tropica. 242:106924
Autor:
Natália Lins da Silva Gomes, Camila Cardoso-Santos, Ana Lia Mazzeti, Ludmila Ferreira de Almeida Fiuza, Denise da Gama Jaen Batista, Cristiane França da Silva, Serge Van Calenbergh, Maria de Nazaré Correia Soeiro, Guy Caljon, Otacilio C. Moreira, Gabriel Melo de Oliveira, Louis Maes, Fabian Hulpia, Roberson Donola Girão
Publikováno v:
JAC-ANTIMICROBIAL RESISTANCE
JAC-Antimicrobial Resistance
JAC-Antimicrobial Resistance
Background The protozoan Trypanosoma cruzi is auxotrophic for purines and causes Chagas’ disease (CD), a neglected illness affecting >6 million people. Combining the 3-deoxyribofuranose part of cordycepin with the modified purine ring of a nucleosi
Autor:
Lavínia de Carvalho Brito, Patrícia Bernardino da Silva, Ludmila Ferreira de Almeida Fiuza, Marcos Meuser Batista, Flávia da C. Camillo, André M. Marques, Raiza Brandão Peres, Maria Raquel Figueiredo, Maria de Nazaré Correia Soeiro
Publikováno v:
Molecules
Volume 26
Issue 18
Molecules, Vol 26, Iss 5676, p 5676 (2021)
Volume 26
Issue 18
Molecules, Vol 26, Iss 5676, p 5676 (2021)
Chagas disease (CD) affects more than 6 million people worldwide. The available treatment is far from ideal, creating a demand for new alternative therapies. Botanical diversity provides a wide range of novel potential therapeutic scaffolds. Presentl
Autor:
Camila, Cardoso-Santos, Ludmila, Ferreira de Almeida Fiuza, Cristiane, França da Silva, Ana Lia, Mazzeti, Roberson, Donola Girão, Gabriel, Melo de Oliveira, Denise, da Gama Jaen Batista, Otacilio, Cruz Moreira, Natália, Lins da Silva Gomes, Louis, Maes, Guy, Caljon, Fabian, Hulpia, Serge V, Calenbergh, Maria de Nazaré, Correia Soeiro
Publikováno v:
JAC-Antimicrobial Resistance
Background The protozoan Trypanosoma cruzi is auxotrophic for purines and causes Chagas’ disease (CD), a neglected illness affecting >6 million people. Combining the 3-deoxyribofuranose part of cordycepin with the modified purine ring of a nucleosi
Autor:
Jakob, Bouton, Ludmila, Ferreira de Almeida Fiuza, Camila, Cardoso Santos, Maria Angela, Mazzarella, Maria de Nazaré Correia, Soeiro, Louis, Maes, Izet, Karalic, Guy, Caljon, Serge, Van Calenbergh
Publikováno v:
Journal of medicinal chemistry. 64(7)
Chagas disease and visceral leishmaniasis are two neglected tropical diseases responsible for numerous deaths around the world. For both, current treatments are largely inadequate, resulting in a continued need for new drug discovery. As both kinetop
Autor:
Gabriel Melo de Oliveira, Aline Nefertiti Silva da Gama, Romina Rocchetti, Monica Cal, Anna F. Fesser, Raiza Brandão Peres, Maria de Nazaré Correia Soeiro, Marianne Rocha-Hasler, Ludmila Ferreira de Almeida Fiuza, Marcel Kaiser, Pascal Mäser, Xue Li Guan
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 11 (2021)
Frontiers in Cellular and Infection Microbiology
Frontiers in Cellular and Infection Microbiology
Azoles such as posaconazole (Posa) are highly potent against Trypanosoma cruzi. However, when tested in chronic Chagas disease patients, a high rate of relapse after Posa treatment was observed. It appears that inhibition of T. cruzi cytochrome CYP51
Autor:
Ludmila Ferreira de Almeida Fiuza, Cai Lin, Camila Cardoso Santos, Jakob Bouton, Guy Caljon, Serge Van Calenbergh, Maria de Nazaré Correia Soeiro, Louis Maes, Fabian Hulpia, Otacilio C. Moreira, Izet Karalic, Daniela Ferreira Nunes
Publikováno v:
ChemMedChem
Chagas disease is a tropical infectious disease resulting in progressive organ-damage and currently lacks efficient treatment and vaccine options. The causative pathogen, Trypanosoma cruzi, requires uptake and processing of preformed purines from the
Autor:
Maria Angela Mazzarella, Camila Cardoso Santos, Serge Van Calenbergh, Maria de Nazaré Correia Soeiro, Izet Karalic, Guy Caljon, Louis Maes, Jakob Bouton, Ludmila Ferreira de Almeida Fiuza
Publikováno v:
Journal of medicinal chemistry
Chagas disease and visceral leishmaniasis are two neglected tropical diseases responsible for numerous deaths around the world. For both, current treatments are largely inadequate, resulting in a continued need for new drug discovery. As both kinetop
Autor:
Geert Jan Sterk, Titilola D. Kalejaiye, Cristiane França da Silva, Julianna Siciliano de Araújo, Maarten Sijm, Rob Leurs, Ludmila Ferreira de Almeida Fiuza, Harry P. de Koning, Cristina Fonseca-Berzal, Denise da Gama Jaen Batista, Louis Maes, Maria de Nazaré Correia Soeiro, A. S. G. Nefertiti, Marcos Meuser Batista, Patrícia Bernardino da Silva
Publikováno v:
Antimicrobial agents and chemotherapy, 64(9):e00414-20, 1-11. American Society for Microbiology
Antimicrobial agents and chemotherapy
de Araújo, J S, França da Silva, C, Batista, D D G J, Nefertiti, A, Fiuza, L F D A, Fonseca-Berzal, C R, Bernardino da Silva, P, Batista, M M, Sijm, M, Kalejaiye, T D, de Koning, H P, Maes, L, Sterk, G J, Leurs, R & Soeiro, M D N C 2020, ' Efficacy of Novel Pyrazolone Phosphodiesterase Inhibitors in Experimental Mouse Models of Trypanosoma cruzi ', Antimicrobial agents and chemotherapy, vol. 64, no. 9, e00414-20, pp. 1-11 . https://doi.org/10.1128/AAC.00414-20
Antimicrob Agents Chemother
Antimicrobial agents and chemotherapy
de Araújo, J S, França da Silva, C, Batista, D D G J, Nefertiti, A, Fiuza, L F D A, Fonseca-Berzal, C R, Bernardino da Silva, P, Batista, M M, Sijm, M, Kalejaiye, T D, de Koning, H P, Maes, L, Sterk, G J, Leurs, R & Soeiro, M D N C 2020, ' Efficacy of Novel Pyrazolone Phosphodiesterase Inhibitors in Experimental Mouse Models of Trypanosoma cruzi ', Antimicrobial agents and chemotherapy, vol. 64, no. 9, e00414-20, pp. 1-11 . https://doi.org/10.1128/AAC.00414-20
Antimicrob Agents Chemother
Pyrazolones are heterocyclic compounds with interesting biological properties. Some derivatives inhibit phosphodiesterases (PDEs) and thereby increase the cellular concentration of cyclic AMP (cAMP), which plays a vital role in the control of metabol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4cfe21cadb9de1ab732be994c539a37c
https://research.vu.nl/en/publications/60532e52-ce8d-4c5f-8df6-e8d9f01083b2
https://research.vu.nl/en/publications/60532e52-ce8d-4c5f-8df6-e8d9f01083b2